Studies have shown that active fund managers routinely underperform the S&P500 index*​

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX)

KPRX Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
86.60%

KPRX Stock Analysis

KPRX PE Ratio:

KPRX PEG Ratio: Not Available

KPRX Forward EPS Growth (12 month): 0.00%

KPRX PS Ratio:

KPRX PSG Ratio: Not Available

KPRX Forward Revenue Growth (12 month): 0.00%

KPRX Articles

No data was found